In vitro activity of thimerosal against ocular pathogenic fungi

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 536-539

  Xu, Yan ^a   Pang, Guangren ^a   Zhao, Dongqing ^a   Gao, Chuanwen ^a   Zhou, Lutan ^a   Sun, Shengtao ^a   Wang, Bingliang ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Anyang Eye Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; NATAMYCIN; THIOMERSAL;

ALTERNARIA ALTERNATA; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS ORYZAE; DILUTION; FUNGUS GROWTH; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL;

ALTERNARIA; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; EYE INFECTIONS, FUNGAL; FUNGI; FUSARIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; NATAMYCIN; THIMEROSAL;

EID: 73849149419     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00714-09     Document Type: Article

References (30)

1. Abrams, J. D., T. G. Davies, and M. Klein. 1965. Mercurial preservatives in eye-drops: observations on patients using miotics containing thimerosal. Br. J. Ophthalmol. 49:146-147.
2. Bhartiya, P., M. Daniell, M. Constantinou, F. M. Islam, and H. R. Taylor. 2007. Fungal keratitis in Melbourne. Clin. Exp. Ophthalmol. 35:124-130.
3. Chen, W. F., J. P. Wang, and G. B. Zhuang. 2000. Treating fungal keratitis with natamycin. Ophthalmol. CHN. 9:179-180.
4. Chowdhary, A., and K. Singh. 2005. Spectrum of fungal keratitis in North India. Cornea 24:8-15.
5. Debbasch, C., F. O. Brignole, P. J. Pisella, and J. M. Warnet. 2001. Quaternary mmoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Investig. Ophthalmol. Vis. Sci. 42:642-652.
6. Gasset, A. R., Y. Ishii, H. E. Kaufman, and T. Miller. 1974. Cytotoxicity of ophthalmic preservatives. Am. J. Ophthalmol. 78:98-105.
7. Höfling-Lima, A. L., A. Forseto, J. P. Duprat, A. Andrade, L. B. Souza, P. Godoy, and D. Freitas. 2005. Laboratory study of the mycotic infectious eye diseases and factors associated with keratitis. Arq. Bras. Oftalmol. 68:21-27.
8. Khairallah, S. H., K. A. Byrne, and K. F. Tabbara. 1992. Fungal keratitis in Saudi Arabia. Doc. Ophthalmol. 79:269-276.
9. Khanal, B., M. Deb, A. Panda, and H. S. Sethi. 2005. Laboratory diagnosis in ulcerative keratitis. Ophthalmic Res. 37:123-127.
10. Lalitha, P., B. L. Shapiro, M. Srinivasan, N. V. Prajna, N. R. Acharya, A. W. Fothergill, J. Ruiz, J. D. Chidambaram, K. J. Maxey, K. C. Hong, S. D. McLeod, and T. M. Lietman. 2007. Antimicrobial susceptibility of fusarium, aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol. 125:789-793.
11. Li, L., Z. Wang, R. Li, S. Luo, and X. Sun. 2008. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am. J. Ophthalmol. 146:724-728.
12. Marangon, F. B., D. Miller, J. A. Giaconi, and E. C. Alfonso. 2004. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am. J. Ophthalmol. 137:820-825.
13. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
14. O'Brien, T. P. 1999. Therapy of ocular fungal infections. Ophthalmol. Clin. North Am. 12:33-50.
15. O'Day, D. M., W. S. Head, R. D. Robinson, and J. A. Clanton. 1986. Corneal penetration of topical amphotericin B and natamycin. Curr. Eye Res. 5:877-882.
16. Qiu, W. Y., Y. F. Yao, Y. F. Zhu, Y. M. Zhang, P. Zhou, Y. Q. Jin, and B. Zhang. 2005. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis. Curr. Eye Res. 30:1113-1120.
17. Saha, R., and S. Das. 2006. Mycological profile of infectious keratitis from Delhi. Indian J. Med. Res. 123:159-164.
18. Sun, X. G., Z. X. Wang, Z. Q. Wang, S. Y. Luo, and R. Li. 2007. Ocular fungal isolates and antifungal susceptibility in northern China. Am. J. Ophthalmol. 143:131-133.
19. Tanure, M. A., E. J. Cohen, S. Sudesh, C. J. Rapuano, and P. R. Laibson. 2000. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 19:307-312.
20. Thomas, P. A. 2003. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev. 16:730-797.
21. Tisner, J., J. Millan, P. Rivas, I. Adiego, A. Castellote, and H. Valles. 1995. Otomycosis and topical application of thimerosal: study of 152 cases. Acta Otorrinolaringol. Esp. 46:85-89.
22. Wang, D. L. (ed.). 2005. Medical mycology-guide to laboratory examination, p. 4-37, 264-374, 421-446. People's Medical Publishing House, Beijing, China.
23. Wang, L. Y., Y. Q. Zhang, Y. Q. Wang, G. S. Wang, J. B. Lu, and J. H. Deng. 2000. Spectrum of mycotic keratitis in China. Chin. J. Ophthalmol. 36:138-140.
24. Wong, T. Y., K. S. Fong, and D. T. Tan. 1997. Clinical and microbial spectrum of fungal keratitis in Singapore: a 5-year retrospective study. Int. Ophthalmol. 21:127-130.
25. Wu, S. X. (ed.). 2005. Identification manual of medical fungi, 2nd ed., p. 60-68, 164-272. Chinese Academy of Medical Sciences & Peking Union Medical College Press, Beijing, China.
26. Xie, L., H. Zhai, J. Zhao, S. Sun, W. Shi, and X. Dong. 2008. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am. J. Ophthalmol. 146:260-265.
27. Xie, L. X. 2003. Fungal keratitis. Chin. J. Ophthalmol. 39:638-640.
28. Xie, L. X., X. G. Dong, and W. Y. Shi. 2001. Treatment of fungal keratitis by penetrating keratoplasty. Br. J. Ophthalmol. 85:1070-1074.
29. Xu, Y., G. R. Pang, D. Q. Zhao, C. W. Gao, L. T. Zhou, S. T. Sun, and B. L. Wang. Activity of butenafine against ocular pathogenic filamentous fungi in vitro. Chin. J. Ophthalmol., in press.
30. Zhong, W. X., S. Y. Sun, J. Zhao, W. Y. Shi, and L. X. Xie. 2007. Retrospective study of suppurative keratitis in 1054 patients. Chin. J. Ophthalmol. 43:245-250.